PlainRecalls
FDA Drug Moderate Class II Terminated

Papaverine/Phentolamine/PGE-1 Injectable, 30 mg/2 mg/20 mcg/mL, 2.5 mL vial, Rx only, Liberty Drug Compound Center, 195 Main St., PO Box 267, Chatham, NJ 07928.

Reported: September 2, 2015 Initiated: June 15, 2015 #D-1384-2015

Product Description

Papaverine/Phentolamine/PGE-1 Injectable, 30 mg/2 mg/20 mcg/mL, 2.5 mL vial, Rx only, Liberty Drug Compound Center, 195 Main St., PO Box 267, Chatham, NJ 07928.

Reason for Recall

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Details

Recalling Firm
Liberty Drug & Surgical
Units Affected
2 vials
Distribution
Physicians, Medical Facilities, and Prescription Specific Patients in NJ and NY
Location
Chatham, NJ

Frequently Asked Questions

What product was recalled?
Papaverine/Phentolamine/PGE-1 Injectable, 30 mg/2 mg/20 mcg/mL, 2.5 mL vial, Rx only, Liberty Drug Compound Center, 195 Main St., PO Box 267, Chatham, NJ 07928.. Recalled by Liberty Drug & Surgical. Units affected: 2 vials.
Why was this product recalled?
Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 2, 2015. Severity: Moderate. Recall number: D-1384-2015.